A Phase I Trial of Autologous Tumour Vaccine for Advanced Solid Cancers
Condition: Solid Tumor Intervention: Biological: Radvax Sponsors: Vaxine Pty Ltd; Australian Respiratory and Sleep Medicine Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2023 Category: Research Source Type: clinical trials
pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS ≥1, hrHPV+ Oropharyngeal Cancer
Conditions: Metastatic Oropharyngeal Carcinoma; Recurrent Oropharyngeal Carcinoma Interventions: Biological: DNA Vaccine; Biological: Human Papillomavirus Tumor Antigen Vaccine; Biological: Pembrolizumab; Procedure: Computed Tomography (CT); Procedure: Magnetic Resonance Imaging (MRI); Procedure: Magnetic Resonance Imaging; Procedure: Biopsy Sponsor: Michael K. Gibson Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2023 Category: Research Source Type: clinical trials
Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer
Condition: Advanced Ovarian Cancer Interventions: Biological: AST-201; Drug: Paclitaxel; Drug: Carboplatin; Drug: Placebo; Drug: rhuGM-CSF(Granulocyte-Macrophage Colony-Stimulating Factor) Sponsor: Aston Sci. Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2023 Category: Research Source Type: clinical trials
